A drug with the SMILES Cc1nn(-c2ccc(F)cc2)c(Cl)c1/C=C/C(=O)OCC(=O)Nc1c(F)c(F)c(F)c(F)c1F has a human ether-à-go-go related gene (hERG) inhibition at a concentration of 1uM of 4.989\%.
A {#drug|compound!} with the {SMILES__description} {SMILES#} has a {herg_central_at_1uM__names__noun} of {herg_central_at_1uM#}{herg_central_at_1uM__units}.
Cc1nn(-c2ccc(F)cc2)c(Cl)c1/C=C/C(=O)OCC(=O)Nc1c(F)c(F)c(F)c(F)c1F
Cc1nn(-c2ccc(F)cc2)c(Cl)c1/C=C/C(=O)OCC(=O)Nc1c(F)c(F)c(F)c(F)c1F
[2-oxo-2-(2,3,4,5,6-pentafluoroanilino)ethyl] (E)-3-[5-chloro-1-(4-fluorophenyl)-3-methylpyrazol-4-yl]prop-2-enoate